ストックスクリーナーアプリを入手
0.6983
11.90%
-0.0943
プレマーケット:
.61
-0.0883
-12.64%
前日終値:
$0.7926
開ける：
$0.7811
24時間の取引高:
349.84K
Relative Volume:
1.29
時価総額：
$31.30M
収益：
$19.94M
当期純損益:
$-37.37M
株価収益率:
-0.6714
EPS:
-1.04
ネットキャッシュフロー:
$-33.38M
1週間 パフォーマンス:
-32.20%
1か月 パフォーマンス:
-40.32%
6か月 パフォーマンス:
-65.60%
1年 パフォーマンス:
-88.36%
1日の値動き範囲:
$0.6951
$0.8201
1週間の範囲:
$0.6951
$1.02
52週間の値動き範囲:
$0.6951
$6.89
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
名前
Werewolf Therapeutics Inc
セクター
電話
617-952-0555
住所
200 TALCOTT AVENUE, WATERTOWN
HOWL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.6983 | 31.30M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-24 | 開始されました | Wedbush | Outperform |
| 2023-06-06 | 再開されました | Jefferies | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-25 | 開始されました | Evercore ISI | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-25 | 開始されました | Jefferies | Buy |
| 2021-05-25 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Werewolf Therapeutics Inc (HOWL) 最新ニュース
Werewolf Therapeutics stock hits 52-week low at $0.85 - Investing.com Australia
Werewolf Therapeutics stock hits 52-week low at $0.85 By Investing.com - Investing.com South Africa
Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Werewolf Therapeutics Reveals Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan
Bank of New York Mellon Corp Grows Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics stock hits 52-week low at $1.02 By Investing.com - Investing.com Australia
Werewolf Therapeutics stock hits 52-week low at $1.02 - Investing.com India
Werewolf Therapeutics Reports 2024 Financial Results and Progress - TipRanks
HC Wainwright Issues Pessimistic Outlook for HOWL Earnings - Defense World
Wedbush Research Analysts Cut Earnings Estimates for HOWL - Defense World
HC Wainwright Reaffirms Buy Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World
Wedbush Reaffirms Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China - TipRanks
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire
Werewolf Therapeutics Inc. (HOWL) reports earnings - Quartz
Werewolf Therapeutics reports Q4 EPS (46c), consensus (31c) - TipRanks
Werewolf Therapeutics, Inc. SEC 10-K Report - TradingView
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides - Bakersfield.com
HOWLWerewolf Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference - GlobeNewswire
What Will Werewolf Therapeutics Reveal at the Leerink Biopharma Conference Next Month? - StockTitan
Werewolf Therapeutics, Inc. Announces Board Changes and Committee Appointment - Marketscreener.com
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Werewolf Therapeutics stock hits 52-week low at $1.25 By Investing.com - Investing.com Canada
Werewolf Therapeutics stock hits 52-week low at $1.25 - Investing.com
Werewolf Therapeutics Announces Board Resignation and New Appointment - Defense World
Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors - GlobeNewswire
Werewolf Therapeutics appoints new board member By Investing.com - Investing.com South Africa
Werewolf Therapeutics appoints new board member - Investing.com India
Can This Oncology Pioneer Transform Werewolf's Cancer-Fighting Platform? - StockTitan
Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) vs. Werewolf Therapeutics (NASDAQ:HOWL) Head to Head Review - Defense World
Barclays PLC Increases Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Up 13.2% in December - MarketBeat
Jane Street Group LLC Trims Holdings in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics' SWOT analysis: stock faces challenges amid pipeline progress - Investing.com
Werewolf Therapeutics (NASDAQ:HOWL) Price Target Lowered to $4.00 at JMP Securities - MarketBeat
JMP Securities Cuts Price Target for Werewolf Therapeutics (NASDAQ:HOWL) to $4.00/Share, Down from $12.00 - HPBL
Werewolf Therapeutics provides business update, highlights 2025 outlook - Yahoo Finance
Werewolf Therapeutics Provides Business Update - citybiz
Werewolf Therapeutics Provides Business Update and Highlights 2025 Strategic Outlook - GlobeNewswire
Werewolf Therapeutics Inc (HOWL) 財務データ
収益
当期純利益
現金流量
EPS
3.01%
大文字化:
|
ボリューム (24 時間):